CNTX is trading at 5.2% up now at $0.64 after a sharp 9.8% gain in the previous session. There are no fresh company-specific headlines, earnings, FDA updates, or major analyst calls dated July 2, 2026, so the move appears to extend recent momentum and sentiment around favorable analyst price targets rather than a new discrete event.